Abstract
DNA is considered as one of the main targets for anticancer drug design. The planar structure of acridines confers to the molecules the ability to bind DNA by intercalation and therefore to interfere with metabolic processes. A large number of natural alkaloids and synthetic acridine derivatives have been tested as anticancer agents. So far, a few molecules have entered clinical trials and have been approved for chemotherapy. The mechanisms of action are not fully understood. Cytotoxicity may be related to potent enzyme inhibition. Topoisomerase and telomerase activities may be strongly affected by acridines. The affinity of acridines for DNA has also been used to design new active compounds in which a DNA modifying group is tethered to the acridine nucleus. Acridine derivatives display other pharmacological properties such as antibacterial and antimalarial activities. They are also tested for Alzheimers disease.
Current Pharmaceutical Design
Title: Interest of Acridine Derivatives in the Anticancer Chemotherapy
Volume: 7 Issue: 17
Author(s): Martine Demeunynck, Franck Charmantray and Alain Martelli
Affiliation:
Abstract: DNA is considered as one of the main targets for anticancer drug design. The planar structure of acridines confers to the molecules the ability to bind DNA by intercalation and therefore to interfere with metabolic processes. A large number of natural alkaloids and synthetic acridine derivatives have been tested as anticancer agents. So far, a few molecules have entered clinical trials and have been approved for chemotherapy. The mechanisms of action are not fully understood. Cytotoxicity may be related to potent enzyme inhibition. Topoisomerase and telomerase activities may be strongly affected by acridines. The affinity of acridines for DNA has also been used to design new active compounds in which a DNA modifying group is tethered to the acridine nucleus. Acridine derivatives display other pharmacological properties such as antibacterial and antimalarial activities. They are also tested for Alzheimers disease.
Export Options
About this article
Cite this article as:
Martine Demeunynck , Franck Charmantray and Alain Martelli , Interest of Acridine Derivatives in the Anticancer Chemotherapy, Current Pharmaceutical Design 2001; 7 (17) . https://dx.doi.org/10.2174/1381612013397131
DOI https://dx.doi.org/10.2174/1381612013397131 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Trend in the Chemistry of Triazolopyrimidines and their Applications
Mini-Reviews in Organic Chemistry A New Perspective on Probing the Interaction of Nicotine with Human Serum Albumin
Current Analytical Chemistry Desmopressin 30 Years in Clinical Use: A Safety Review
Current Drug Safety Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery
Current Pharmaceutical Design Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Alzheimer’s Disease Amyloid Peptides Interact with DNA, As Proved by Surface Plasmon Resonance
Current Alzheimer Research Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients
Central Nervous System Agents in Medicinal Chemistry Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Current Pharmaceutical Design Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease
Current Pharmaceutical Design Neuroprotective Effect of β-secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate
Current Alzheimer Research The Leading Role of Antimicrobial Agents in Modulating the Binomial Host-Microorganism
Current Medicinal Chemistry - Anti-Infective Agents Chemotherapeutic Effects of Acridine Derivatives
Medicinal Chemistry Reviews - Online (Discontinued) Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design Microglia and Inflammation in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Neuroinflammation and its Modulation by Flavonoids
Endocrine, Metabolic & Immune Disorders - Drug Targets CCR1 Chemokine Receptor Antagonist
Current Pharmaceutical Design Toxic Metals in Herbal Medicines. A Review
Current Bioactive Compounds Malignant Hyperthermia: A Pharmacogenetic Disease of Ca++ Regulating Proteins
Current Molecular Medicine Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs
Current Medicinal Chemistry - Central Nervous System Agents Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry